Julio Martinez Clark breaks down how Bio Access helps founders protect their burn rate while getting to first in human data faster. He explains why time to site activation matters more than line item budgets, how to think about patient recruitment in emerging markets, and what inexperienced PhD and physician founders usually overlook when they try to manage overseas trials without an expert clinical operations partner.
